Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.
about
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.Role of RANK and Akt1 activation in human osteosarcoma progression: A clinicopathological study.The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma.Cancer Epigenetics: Mechanisms and Crosstalk of a HDAC Inhibitor, VorinostatUp-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.Epigenetic Regulators: New Therapeutic Targets for Soft Tissue Sarcoma.miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22ARETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaHistone Deacetylases in Bone Development and Skeletal Disorders.Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma.Identification of Synergistic, Clinically Achievable, Combination Therapies for OsteosarcomaSustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma CellsMicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.Downregulation of 14q32 microRNAs in Primary Human Desmoplastic MedulloblastomaBruceantin inhibits multiple myeloma cancer stem cell proliferation.Epigenetic alterations in osteosarcoma: promising targets.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profilingRadiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model.Therapeutic applications of histone deacetylase inhibitors in sarcoma.Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathwaysEradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20.Comparative aspects of MicroRNA Expression in Canine and Human Cancer.Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications.Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs.Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma
P2860
Q33646069-237DB802-72DD-4BC0-8CD6-26916D9C7A5AQ33744585-3CD506EB-4B4B-4A00-810E-221068AD2560Q33905746-BF491079-BB34-47EE-B772-1645028015B9Q34213967-C620446F-7384-42F7-9461-06C0CDE50090Q35641383-18E29F5A-6AD1-4D69-A15E-480457A9E73AQ35734256-E0B7E3D7-851D-4932-95E3-2AD3044A5DA7Q35780039-7B820EF0-8928-4303-934A-20D073694AD9Q36131618-4FD377AF-4466-4EF5-9C03-1E071E0C46ECQ36146330-97E718EC-5806-4828-937D-846BF106E58DQ36256343-B85E6116-65EB-4146-998B-A990BFCBE8D2Q36301216-B50A40B0-BC0F-428F-AB95-13C1824207F1Q36316518-81A3E528-0951-4508-8389-3F3FB8700F3DQ36702019-0EE73BC7-D203-4C3E-B16C-50CDCD6DF9B4Q36944910-6AA528F2-6F11-436C-9232-27B9720D3F0DQ37196585-8825A39D-26BF-43BF-A592-C514D68BD2D3Q37283018-971F72E2-6425-4EAC-B5B2-2B421DD3172FQ38185555-422DAED8-4DE6-4503-AA95-F51E934D0AEBQ38572855-16297A2A-7863-4C92-A7B2-9136393810E6Q38885306-10BE5A32-030A-4960-B99B-E8EFEF5FFF6BQ39134963-85D526C2-45BC-4194-A286-EF4C9D2AF93CQ39450827-DE005D8E-6E6F-460D-92CE-FD0DD96473E5Q41016177-9F5A4C50-E986-4763-AF70-4DEE3E0950F0Q45033916-08EE5B88-E4F9-48A2-841A-7CE6D146E4B9Q46304395-A1ABC1D4-68B5-4DD0-92CD-617E77ED5862Q47132356-D27D314C-4F57-441F-A12F-BCDBD541C40BQ47912546-CE17528A-436C-4DCD-9401-0C498C19E48CQ48158355-C23472EF-2BE8-418C-9575-76045B419736Q52689154-285207CE-0942-4667-92EB-4F7164C38332Q56486862-CB39474B-D997-492E-9699-F29F2E50B85C
P2860
Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@ast
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@en
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@nl
type
label
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@ast
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@en
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@nl
prefLabel
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@ast
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@en
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@nl
P2093
P2860
P50
P1433
P1476
Combinatorial treatment of DNA ...... anine osteosarcoma cell lines.
@en
P2093
Aaron L Sarver
Ashley J Graef
ChangWon Park
Clifford J Steer
Derek M Korpela
Venugopal Thayanithy
P2860
P304
P356
10.1371/JOURNAL.PONE.0043720
P407
P577
2012-09-05T00:00:00Z